Beyond angels and demons? The past, present, and future of drug abuse liability assessment
<!--StartFragment--> <p class="MsoNormal" style="text-align: justify;"><span style="font-size: 13.0pt; mso-bidi-font-size: 10.0pt; font-family: Garamond;" lang="EN-US">The process by which new drugs are scheduled and e...
Guardado en:
Autor principal: | |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Amsterdam Law Forum
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c38ce80ed9f041b181b41b3d15c30e24 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sumario: | <!--StartFragment--> <p class="MsoNormal" style="text-align: justify;"><span style="font-size: 13.0pt; mso-bidi-font-size: 10.0pt; font-family: Garamond;" lang="EN-US">The process by which new drugs are scheduled and existing drugs rescheduled is among the most critical elements in the modern system of drug control.<span style="mso-spacerun: yes;">&nbsp; </span>For all of its importance, it remains a deeply flawed process, poorly understood by scholars.<span style="mso-spacerun: yes;">&nbsp; </span>This essay examines a core element in this process &ndash; drug abuse liability assessment &ndash; from an historical perspective. The review argues that the role of law and corporations in the sorting process must be better understood, and concludes with an overview of three critical issues that have frustrated drug abuse liability assessment in the past.&nbsp;</span></p> <!--EndFragment--> |
---|